Description: Presented at Living to 100 and Beyond symposium 2002. Discussion on 'Living to Age 100 in Canada in 2000' by Doray and 'Oldest-Old Mortality Rates and the Gompertz Law: A Theoretical and Empirical Study Based on Four Countries' by Yue papers.

Description: The abstract for the paper IDL, the International Database on Longevity.

Description: This paper explores how mortality tables have been ended in the past addresses the question as to whether an ending rate of 1.000 is most appropriate. From 2005 Living to 100 and Beyond Monograph, M-LI05-1.

Description: Expert discussion. From 2005 Living to 100 and Beyond Monograph, M-LI05-1.

Description: This article discusses whether or not life expectancy will continue to increase.

Description: With improved global mortality confirmed, the question becomes: What adjustments do actuaries need to make? This article answers that and other questions related to mortality improvements.

Description: Presented at Living to 100 Symposium, January 2011. This paper addresses the question of how socioeconomic and demographic characteristics, health status and health behaviors are associated with oldest-old mortality and survivorship among people who have survived to old age. Data comes from the 1990-91 National Health Interview Survey’s Health Promotion and Disease Prevention Supplement and the mortality follow-up through 2002. The results indicate that activity limitation and exercise status, in combination with education, play an important role in survival into ages between 65 and 85, but have a smaller effect on survival among the oldest-old population of 85+.

Description: Presented at Living to 100 symposium, January 2011. This paper investigates dynamic properties of age trajectories of physiological indices and their effects on mortality risk and longevity using longitudinal data on more than 5,000 individuals collected in biannual examinations of the Framingham Heart Study original age group during about 50 subsequent years of follow up.

Description: This is the informal discussion transcript from Session 5A: Mortality and Longevity Research from the January 4-6, 2017 Living to 100 Symposium in Orlando.

Description: Discussion of the differences between aging and disease research and factors affecting longevity. Argues that elimination of most mortality risk will not create a dramatic increase in life expectancy.